信号淋巴细胞活化分子CD150抗体Quantity size:
0.2ml
Concentration:
1mg/ml Buffer = 0.01M TBS(pH7.4) with 1% BSA, 0.03% Proclin300 and 50% Glycerol.
Background:
SLAM, a novel glycoprotein of 37kDa, designated SLAM (Signaling Lymphocyte Activation Molecule) or CDw150, belongs to the immunoglobulin gene superfamily and is involved in T cell stimulation. SLAM is constitutively expressed on peripheral blood memory T cells, T cell clones,信号淋巴细胞活化分子CD150抗体immature thymocytes, and a proportion of B cells, and is rapidly induced on naive T cells after activation. Activated B cells express the membrane bound form of SLAM and the soluble and cytoplasmic isoforms of SLAM, and the expression levels of membrane bound SLAM on B cells are rapidly regulated after activation in vitro.信号淋巴细胞活化分子CD150抗体 It is suggested that signalling through homophilic SLAM-SLAM binding during B to B and B to T cell interactions enhances the expansion and differentiation of activated B cells. Reports suggest that the extracellular domain of CD150 is the receptor for the measles virus and acts as a co-activator on T cells and B cells.
信号淋巴细胞活化分子CD150抗体Also known as:
CD150 antigen; Cdw150; SLAM / CD150; Estm51; Ipo 3; Ipo3; MGC151472; MGC151476; Signaling lymphocytic activation molecule; Signaling lymphocytic activation molecule family member 1; Signaling lymphocytic activation molecule precursor; Slaf1; SLAM family, member 1; Slamf; Slamf1; SLAMF1 protein.
Specificity:
●
Rabbit Polyclonal IgG, affinity purified by Protein A.
●
Reacts with: Human, Mouse, Rat, Dog, Pig, Cow, Horse, Sheep, .
●
Immunogen: KLH conjugated synthetic peptide derived from human CD150.
●
信号淋巴细胞活化分子CD150抗体Predicted Molecular Weight: 70kDa.
Storage:
Shipped at 4℃, Store at -20℃ (Avoid repeated freeze/thaw cycles).
Application:
WB=1:100-500 ELISA=1:500-1000 IHC-P=1:100-500 IHC-F=1:100-500 IF=1:100-500
Not yet tested in other applications.
Optimal working dilutions must be determined by the end user.
kl313Hu01抗凝血酶(AT)多克隆抗体Polyclonal Antibody to Antithrombin (AT)
kl313Mu01抗凝血酶(AT)多克隆抗体Polyclonal Antibody to Antithrombin (AT)
kl313Ra01抗凝血酶(AT)多克隆抗体Polyclonal Antibody to Antithrombin (AT)
kl820Hu01凝血因子Ⅱ(F2)多克隆抗体Polyclonal Antibody to Coagulation Factor II (F2)
kl820Mu01凝血因子Ⅱ(F2)多克隆抗体Polyclonal Antibody to Coagulation Factor II (F2)
kl820Ra01凝血因子Ⅱ(F2)多克隆抗体Polyclonal Antibody to Coagulation Factor II (F2)
kl353Ge01晚期糖基化终末产物(AGE)多克隆抗体Polyclonal Antibody to Advanced Glycation End Product (AGE)
kl929Hu01视黄醇结合蛋白4(RBP4)多克隆抗体Polyclonal Antibody to Retinol Binding Protein 4, Plasma (RBP4)
kl929Mu01视黄醇结合蛋白4(RBP4)多克隆抗体Polyclonal Antibody to Retinol Binding Protein 4, Plasma (RBP4)
kl929Ra01视黄醇结合蛋白4(RBP4)多克隆抗体Polyclonal Antibody to Retinol Binding Protein 4, Plasma (RBP4)
kl367Hu01视黄醇结合蛋白3(RBP3)多克隆抗体Polyclonal Antibody to Retinol Binding Protein 3, Interstitial (RBP3)
kl367Mu01视黄醇结合蛋白3(RBP3)多克隆抗体Polyclonal Antibody to Retinol Binding Protein 3, Interstitial (RBP3)
kl367Ra01视黄醇结合蛋白3(RBP3)多克隆抗体Polyclonal Antibody to Retinol Binding Protein 3, Interstitial (RBP3)
kl377Hu01视黄醇结合蛋白2(RBP2)多克隆抗体Polyclonal Antibody to Retinol Binding Protein 2, Cellular (RBP2)
kl377Mu01视黄醇结合蛋白2(RBP2)多克隆抗体Polyclonal Antibody to Retinol Binding Protein 2, Cellular (RBP2)
kl377Ra01视黄醇结合蛋白2(RBP2)多克隆抗体Polyclonal Antibody to Retinol Binding Protein 2, Cellular (RBP2)
kl400Hu01视黄醇结合蛋白1(RBP1)多克隆抗体Polyclonal Antibody to Retinol Binding Protein 1, Cellular (RBP1)
kl400Mu01视黄醇结合蛋白1(RBP1)多克隆抗体Polyclonal Antibody to Retinol Binding Protein 1, Cellular (RBP1)
更多
企业名称
上海康朗生物科技有限公司
企业信息已认证
企业类型
信用代码
310112001510759
成立日期
2015-05-29
注册资本
100
经营范围
从事生物科技技术领域内技术开发、技术咨询、技术服务、技术转让,实验分析仪器、化工产品及原料(除危险化学品、监控化学品、烟花爆竹、民用爆竹物品、易制毒化学品)、仪器仪表、环保设备、酒店用品、皮革制品、床上用品、电子产品的销售。【依法须经批准的项目,经相关部门批准后方可开展经营活动】
上海康朗生物科技有限公司
公司地址
上海市闵行区闵北路88弄1-30号第22栋BV145室
客服电话